Determining factors for dexmedetomidine sedation in endoscopic submucosal dissection for early‐stage gastric cancer

Determining factors for dexmedetomidine sedation in endoscopic submucosal dissection for early‐stage gastric cancer

Abstract Background and Aim Although no specific sedation recommendations exist in early‐stage gastric cancer (ESGC) for endoscopic submucosal dissection (ESD), dexmedetomidine (DEX) is useful along with benzodiazepines and analgesics. Furthermore, DEX is used for endoscopic treatment requiring leng...

Full description

Saved in:
Bibliographic Details
Main Authors: Erika Yoshida, Yorimasa Yamamoto, Misako Tohata, Kuniyo Gomi, Tadashi Okayasu, Masatsugu Nagahama
Format: Article
Language:English
Published: Wiley 2024-05-01
Series:JGH Open
Subjects:
dexmedetomidine
early‐stage gastric cancer
endoscopic submucosal dissection
Online Access:https://doi.org/10.1002/jgh3.13065
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items